

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron remodeling (GO:0016322) | 8.61633460 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.43408206 |
| 3 | central nervous system myelination (GO:0022010) | 6.43408206 |
| 4 | meiotic chromosome segregation (GO:0045132) | 4.94863340 |
| 5 | retinal cone cell development (GO:0046549) | 4.74582513 |
| 6 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.73642425 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.68876042 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.43379235 |
| 9 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.43135969 |
| 10 | detection of light stimulus involved in visual perception (GO:0050908) | 4.43135969 |
| 11 | presynaptic membrane organization (GO:0097090) | 4.28223963 |
| 12 | behavioral response to nicotine (GO:0035095) | 4.13054506 |
| 13 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.07955072 |
| 14 | synapsis (GO:0007129) | 3.91351401 |
| 15 | regulation of meiosis I (GO:0060631) | 3.89716575 |
| 16 | protein K11-linked deubiquitination (GO:0035871) | 3.81619005 |
| 17 | fucose catabolic process (GO:0019317) | 3.74855752 |
| 18 | L-fucose metabolic process (GO:0042354) | 3.74855752 |
| 19 | L-fucose catabolic process (GO:0042355) | 3.74855752 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 3.73875104 |
| 21 | tryptophan metabolic process (GO:0006568) | 3.72454046 |
| 22 | indolalkylamine metabolic process (GO:0006586) | 3.69331680 |
| 23 | postsynaptic membrane organization (GO:0001941) | 3.65688868 |
| 24 | tryptophan catabolic process (GO:0006569) | 3.60472225 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 3.60472225 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 3.60472225 |
| 27 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.59680857 |
| 28 | regulation of pigment cell differentiation (GO:0050932) | 3.57838983 |
| 29 | prenylation (GO:0097354) | 3.54031113 |
| 30 | protein prenylation (GO:0018342) | 3.54031113 |
| 31 | neuron maturation (GO:0042551) | 3.53522692 |
| 32 | limb bud formation (GO:0060174) | 3.53302335 |
| 33 | resolution of meiotic recombination intermediates (GO:0000712) | 3.51943961 |
| 34 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.48404704 |
| 35 | male meiosis (GO:0007140) | 3.46793147 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.46542604 |
| 37 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.46115923 |
| 38 | C4-dicarboxylate transport (GO:0015740) | 3.42788274 |
| 39 | piRNA metabolic process (GO:0034587) | 3.41246607 |
| 40 | ensheathment of neurons (GO:0007272) | 3.39124272 |
| 41 | axon ensheathment (GO:0008366) | 3.39124272 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 3.38676008 |
| 43 | myelination (GO:0042552) | 3.34417510 |
| 44 | replication fork processing (GO:0031297) | 3.29038804 |
| 45 | axoneme assembly (GO:0035082) | 3.28547885 |
| 46 | DNA double-strand break processing (GO:0000729) | 3.28044746 |
| 47 | oligodendrocyte differentiation (GO:0048709) | 3.26134811 |
| 48 | positive regulation of prostaglandin secretion (GO:0032308) | 3.26097170 |
| 49 | superoxide anion generation (GO:0042554) | 3.25923852 |
| 50 | regulation of glucokinase activity (GO:0033131) | 3.25487181 |
| 51 | regulation of hexokinase activity (GO:1903299) | 3.25487181 |
| 52 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.23843613 |
| 53 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.23843613 |
| 54 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.23843613 |
| 55 | reciprocal meiotic recombination (GO:0007131) | 3.21038873 |
| 56 | reciprocal DNA recombination (GO:0035825) | 3.21038873 |
| 57 | fatty acid elongation (GO:0030497) | 3.20339825 |
| 58 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.19847871 |
| 59 | magnesium ion transport (GO:0015693) | 3.18835683 |
| 60 | one-carbon compound transport (GO:0019755) | 3.18365190 |
| 61 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.18174039 |
| 62 | estrogen biosynthetic process (GO:0006703) | 3.16202063 |
| 63 | photoreceptor cell development (GO:0042461) | 3.14956831 |
| 64 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.12489516 |
| 65 | import into cell (GO:0098657) | 3.11787922 |
| 66 | ketone body metabolic process (GO:1902224) | 3.10955860 |
| 67 | nerve growth factor signaling pathway (GO:0038180) | 3.07119561 |
| 68 | L-amino acid import (GO:0043092) | 3.06565526 |
| 69 | negative regulation of protein localization to cell surface (GO:2000009) | 3.03300747 |
| 70 | coenzyme catabolic process (GO:0009109) | 2.98115915 |
| 71 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.97768040 |
| 72 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.97182320 |
| 73 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.97042317 |
| 74 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.97042317 |
| 75 | regulation of timing of cell differentiation (GO:0048505) | 2.96174621 |
| 76 | serotonin receptor signaling pathway (GO:0007210) | 2.94244327 |
| 77 | male meiosis I (GO:0007141) | 2.93542673 |
| 78 | cranial nerve structural organization (GO:0021604) | 2.93376170 |
| 79 | regulation of collateral sprouting (GO:0048670) | 2.92690922 |
| 80 | eye photoreceptor cell development (GO:0042462) | 2.90559359 |
| 81 | peptidyl-histidine modification (GO:0018202) | 2.87698711 |
| 82 | recombinational repair (GO:0000725) | 2.85358422 |
| 83 | double-strand break repair via homologous recombination (GO:0000724) | 2.84746203 |
| 84 | neural tube formation (GO:0001841) | 2.84118591 |
| 85 | positive regulation of vasculogenesis (GO:2001214) | 2.83030312 |
| 86 | glycerophospholipid catabolic process (GO:0046475) | 2.82531351 |
| 87 | aggressive behavior (GO:0002118) | 2.81529452 |
| 88 | positive regulation of fatty acid transport (GO:2000193) | 2.81314434 |
| 89 | interkinetic nuclear migration (GO:0022027) | 2.80649579 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 2.80090739 |
| 91 | rRNA methylation (GO:0031167) | 2.79133775 |
| 92 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.78119612 |
| 93 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.77904311 |
| 94 | gamma-aminobutyric acid transport (GO:0015812) | 2.77751102 |
| 95 | transmission of nerve impulse (GO:0019226) | 2.77549646 |
| 96 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.77416187 |
| 97 | glutamate receptor signaling pathway (GO:0007215) | 2.77178722 |
| 98 | developmental pigmentation (GO:0048066) | 2.77026274 |
| 99 | cell wall macromolecule catabolic process (GO:0016998) | 2.76168820 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.76007878 |
| 101 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75384613 |
| 102 | facial nerve structural organization (GO:0021612) | 2.75144626 |
| 103 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.73474219 |
| 104 | righting reflex (GO:0060013) | 2.72029234 |
| 105 | rRNA catabolic process (GO:0016075) | 2.71894505 |
| 106 | positive regulation of action potential (GO:0045760) | 2.70396943 |
| 107 | regulation of prostaglandin secretion (GO:0032306) | 2.69655070 |
| 108 | indole-containing compound metabolic process (GO:0042430) | 2.69473762 |
| 109 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.69436272 |
| 110 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.68667311 |
| 111 | DNA deamination (GO:0045006) | 2.67258637 |
| 112 | retina layer formation (GO:0010842) | 2.67210103 |
| 113 | dicarboxylic acid catabolic process (GO:0043649) | 2.66749557 |
| 114 | nucleotide transmembrane transport (GO:1901679) | 2.64165101 |
| 115 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.64157485 |
| 116 | * photoreceptor cell maintenance (GO:0045494) | 2.63228204 |
| 117 | histone H2B ubiquitination (GO:0033523) | 2.62006615 |
| 118 | photoreceptor cell differentiation (GO:0046530) | 2.60153798 |
| 119 | eye photoreceptor cell differentiation (GO:0001754) | 2.60153798 |
| 120 | neuronal action potential propagation (GO:0019227) | 2.58853716 |
| 121 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.58774508 |
| 122 | parental behavior (GO:0060746) | 2.58383562 |
| 123 | kidney morphogenesis (GO:0060993) | 2.55226961 |
| 124 | regulation of heat generation (GO:0031650) | 2.54567238 |
| 125 | rhodopsin mediated signaling pathway (GO:0016056) | 2.53702159 |
| 126 | meiosis I (GO:0007127) | 2.52651132 |
| 127 | G-protein coupled receptor internalization (GO:0002031) | 2.52513853 |
| 128 | startle response (GO:0001964) | 2.52358321 |
| 129 | * visual perception (GO:0007601) | 2.51903416 |
| 130 | multicellular organism reproduction (GO:0032504) | 2.51239390 |
| 131 | epithelial cilium movement (GO:0003351) | 2.51110163 |
| 132 | negative regulation of mast cell activation (GO:0033004) | 2.49691061 |
| 133 | rRNA modification (GO:0000154) | 2.49224407 |
| 134 | protein localization to synapse (GO:0035418) | 2.49048054 |
| 135 | * sensory perception of light stimulus (GO:0050953) | 2.48499477 |
| 136 | negative regulation of protein oligomerization (GO:0032460) | 2.47836845 |
| 137 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.47453366 |
| 138 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.47150621 |
| 139 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46797021 |
| 140 | positive regulation of organic acid transport (GO:0032892) | 2.45859761 |
| 141 | alanine transport (GO:0032328) | 2.45295367 |
| 142 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.44006449 |
| 143 | chromosome organization involved in meiosis (GO:0070192) | 2.43533913 |
| 144 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.43249976 |
| 145 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.43249976 |
| 146 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.43118526 |
| 147 | short-term memory (GO:0007614) | 2.42408462 |
| 148 | mannosylation (GO:0097502) | 2.42142417 |
| 149 | cilium morphogenesis (GO:0060271) | 2.41427629 |
| 150 | sphingoid metabolic process (GO:0046519) | 2.41166264 |
| 151 | gene silencing by RNA (GO:0031047) | 2.40747377 |
| 152 | regulation of platelet aggregation (GO:0090330) | 2.40349304 |
| 153 | protein K6-linked ubiquitination (GO:0085020) | 2.39986501 |
| 154 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.39870214 |
| 155 | neuron recognition (GO:0008038) | 2.38751557 |
| 156 | neuronal action potential (GO:0019228) | 2.38676556 |
| 157 | vocalization behavior (GO:0071625) | 2.37646411 |
| 158 | cyclic nucleotide catabolic process (GO:0009214) | 2.36228184 |
| 159 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.36006317 |
| 160 | GPI anchor metabolic process (GO:0006505) | 2.35704853 |
| 161 | amino acid import (GO:0043090) | 2.35642243 |
| 162 | regulation of development, heterochronic (GO:0040034) | 2.33422437 |
| 163 | isoprenoid biosynthetic process (GO:0008299) | 2.32972783 |
| 164 | cranial nerve development (GO:0021545) | 2.31849381 |
| 165 | positive regulation of interleukin-17 production (GO:0032740) | 2.31786072 |
| 166 | cellular response to epinephrine stimulus (GO:0071872) | 2.29521909 |
| 167 | cAMP-mediated signaling (GO:0019933) | 2.27941965 |
| 168 | neuronal ion channel clustering (GO:0045161) | 2.27699190 |
| 169 | response to pheromone (GO:0019236) | 2.27512113 |
| 170 | response to redox state (GO:0051775) | 2.27246998 |
| 171 | regulation of somitogenesis (GO:0014807) | 2.27041348 |
| 172 | positive regulation of synapse assembly (GO:0051965) | 2.23298521 |
| 173 | GPI anchor biosynthetic process (GO:0006506) | 2.22904393 |
| 174 | cranial nerve morphogenesis (GO:0021602) | 2.22716723 |
| 175 | calcium ion import (GO:0070509) | 2.22129016 |
| 176 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.21913741 |
| 177 | response to epinephrine (GO:0071871) | 2.20732396 |
| 178 | positive regulation of interleukin-10 production (GO:0032733) | 2.19286118 |
| 179 | organ growth (GO:0035265) | 2.19149220 |
| 180 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.18083063 |
| 181 | negative regulation of synaptic transmission (GO:0050805) | 2.16876903 |
| 182 | positive regulation of protein kinase C signaling (GO:0090037) | 2.16798383 |
| 183 | synaptic transmission, glutamatergic (GO:0035249) | 2.15624942 |
| 184 | membrane assembly (GO:0071709) | 2.14496018 |
| 185 | reflex (GO:0060004) | 2.13820803 |
| 186 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.13191488 |
| 187 | adult walking behavior (GO:0007628) | 2.12990930 |
| 188 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.12801780 |
| 189 | protein heterotetramerization (GO:0051290) | 2.11403914 |
| 190 | lateral sprouting from an epithelium (GO:0060601) | 2.11226486 |
| 191 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.11215883 |
| 192 | enteric nervous system development (GO:0048484) | 2.10735138 |
| 193 | neuron-neuron synaptic transmission (GO:0007270) | 2.10084468 |
| 194 | regulation of glutamate secretion (GO:0014048) | 2.07967481 |
| 195 | nonmotile primary cilium assembly (GO:0035058) | 2.07680136 |
| 196 | regulation of respiratory system process (GO:0044065) | 2.07314242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.90927243 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77874106 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.44625813 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.82731784 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71980130 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58266023 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42933079 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41648277 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41613061 |
| 10 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40360629 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37744816 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34324586 |
| 13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.33024035 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26722864 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26722864 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.12991514 |
| 17 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.11263032 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07489475 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06343633 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03531682 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00069473 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96696561 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95250384 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94915346 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94742400 |
| 26 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.94089101 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.92030087 |
| 28 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.91811162 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91250849 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90297412 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85443003 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83190867 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78420680 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77671497 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75674016 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74426920 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.71857795 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70919698 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69513546 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67426919 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64664728 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61686802 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60182560 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60032560 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59292814 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58959759 |
| 47 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54561101 |
| 48 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.53826123 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53503733 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52800190 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52800190 |
| 52 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52638691 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.51244174 |
| 54 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.50273097 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49769770 |
| 56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48976397 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48350041 |
| 58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48169475 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47575646 |
| 60 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.47291517 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45609991 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44214838 |
| 63 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42723142 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42222094 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41841121 |
| 66 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.41552391 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40580984 |
| 68 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.39780482 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38336365 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38054496 |
| 71 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37560896 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37501346 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37332888 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37196329 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36441029 |
| 76 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.35685885 |
| 77 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.35626142 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.35232087 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35178289 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34658743 |
| 81 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34459612 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34106298 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33422357 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33298835 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33067625 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33067625 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31741841 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31650609 |
| 89 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.31187863 |
| 90 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30710438 |
| 91 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29686668 |
| 92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29421202 |
| 93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26556937 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25701522 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25437715 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25437715 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25220478 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24852629 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24580359 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24075500 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23104089 |
| 102 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.23027967 |
| 103 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21219449 |
| 104 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.20556084 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19759464 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19719142 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18438741 |
| 108 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17847192 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17667930 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17667930 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17150636 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16653935 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16597263 |
| 114 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.16480595 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16440128 |
| 116 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.15799130 |
| 117 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15721380 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14753008 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13619789 |
| 120 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.13429105 |
| 121 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13260873 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12621802 |
| 123 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.12500708 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12346570 |
| 125 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12328314 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12235812 |
| 127 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12121832 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12059933 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10686080 |
| 130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09546568 |
| 131 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08181671 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06278948 |
| 133 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06101931 |
| 134 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05661661 |
| 135 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.05125739 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04005961 |
| 137 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.03707220 |
| 138 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03407282 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03265461 |
| 140 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02223323 |
| 141 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01876555 |
| 142 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01602234 |
| 143 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00082525 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99755843 |
| 145 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99580463 |
| 146 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98406052 |
| 147 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97682066 |
| 148 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96034949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.74840279 |
| 2 | MP0005409_darkened_coat_color | 3.61381830 |
| 3 | MP0003136_yellow_coat_color | 3.21925323 |
| 4 | MP0001188_hyperpigmentation | 3.01701673 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.94948168 |
| 6 | MP0008877_abnormal_DNA_methylation | 2.91440952 |
| 7 | MP0003880_abnormal_central_pattern | 2.84241022 |
| 8 | MP0005171_absent_coat_pigmentation | 2.81230158 |
| 9 | MP0001486_abnormal_startle_reflex | 2.69601195 |
| 10 | MP0000566_synostosis | 2.50080398 |
| 11 | MP0002102_abnormal_ear_morphology | 2.48966773 |
| 12 | * MP0004742_abnormal_vestibular_system | 2.45753352 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.39534121 |
| 14 | MP0004381_abnormal_hair_follicle | 2.37836434 |
| 15 | MP0000920_abnormal_myelination | 2.36935791 |
| 16 | MP0002736_abnormal_nociception_after | 2.20055487 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.14372974 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.13600186 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.08465455 |
| 20 | MP0008260_abnormal_autophagy | 2.07393949 |
| 21 | MP0009697_abnormal_copulation | 2.06348697 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.94468550 |
| 23 | MP0002272_abnormal_nervous_system | 1.91673342 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.90086850 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87854276 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.85780413 |
| 27 | MP0003718_maternal_effect | 1.85192703 |
| 28 | MP0008872_abnormal_physiological_respon | 1.82315252 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.79547404 |
| 30 | MP0003787_abnormal_imprinting | 1.79276034 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.79149100 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.72901876 |
| 33 | MP0009745_abnormal_behavioral_response | 1.71596946 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.71432984 |
| 35 | MP0003690_abnormal_glial_cell | 1.69083629 |
| 36 | MP0004270_analgesia | 1.69059575 |
| 37 | MP0009046_muscle_twitch | 1.68818640 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.66475215 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.62250992 |
| 40 | MP0004885_abnormal_endolymph | 1.62212037 |
| 41 | * MP0001963_abnormal_hearing_physiology | 1.60839583 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.60771354 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.58859049 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.55817515 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.55202616 |
| 46 | * MP0000026_abnormal_inner_ear | 1.54671812 |
| 47 | MP0002064_seizures | 1.54502406 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.53542400 |
| 49 | MP0003011_delayed_dark_adaptation | 1.53510171 |
| 50 | MP0001905_abnormal_dopamine_level | 1.52967898 |
| 51 | MP0002063_abnormal_learning/memory/cond | 1.50571306 |
| 52 | MP0004134_abnormal_chest_morphology | 1.49472793 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.48610262 |
| 54 | MP0000778_abnormal_nervous_system | 1.48397055 |
| 55 | MP0003635_abnormal_synaptic_transmissio | 1.47758836 |
| 56 | MP0003938_abnormal_ear_development | 1.46138878 |
| 57 | MP0000427_abnormal_hair_cycle | 1.45302474 |
| 58 | MP0005670_abnormal_white_adipose | 1.45077649 |
| 59 | MP0004043_abnormal_pH_regulation | 1.44693693 |
| 60 | MP0002160_abnormal_reproductive_system | 1.43906667 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.42649755 |
| 62 | MP0001661_extended_life_span | 1.39908951 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.39398778 |
| 64 | MP0004142_abnormal_muscle_tone | 1.38000536 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.35306674 |
| 66 | MP0005451_abnormal_body_composition | 1.33574518 |
| 67 | MP0008995_early_reproductive_senescence | 1.33166922 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.32532883 |
| 69 | MP0003646_muscle_fatigue | 1.30098382 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.26152425 |
| 71 | MP0002184_abnormal_innervation | 1.25419809 |
| 72 | MP0001970_abnormal_pain_threshold | 1.25079423 |
| 73 | MP0000462_abnormal_digestive_system | 1.23446676 |
| 74 | MP0001529_abnormal_vocalization | 1.22828750 |
| 75 | MP0005389_reproductive_system_phenotype | 1.22827520 |
| 76 | * MP0002752_abnormal_somatic_nervous | 1.19729367 |
| 77 | MP0008057_abnormal_DNA_replication | 1.19685762 |
| 78 | MP0000516_abnormal_urinary_system | 1.19529408 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.19529408 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.19508333 |
| 81 | MP0003698_abnormal_male_reproductive | 1.19507233 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.18423128 |
| 83 | MP0005646_abnormal_pituitary_gland | 1.16755907 |
| 84 | MP0002249_abnormal_larynx_morphology | 1.16370590 |
| 85 | MP0008569_lethality_at_weaning | 1.16057790 |
| 86 | MP0005365_abnormal_bile_salt | 1.15223767 |
| 87 | MP0009250_abnormal_appendicular_skeleto | 1.15075138 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.12598951 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.10667298 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 1.10471058 |
| 91 | MP0008058_abnormal_DNA_repair | 1.10409840 |
| 92 | MP0001929_abnormal_gametogenesis | 1.10374783 |
| 93 | MP0004147_increased_porphyrin_level | 1.06847650 |
| 94 | MP0005332_abnormal_amino_acid | 1.06655699 |
| 95 | MP0005253_abnormal_eye_physiology | 1.05712808 |
| 96 | MP0001756_abnormal_urination | 1.04476538 |
| 97 | MP0000049_abnormal_middle_ear | 1.04441768 |
| 98 | MP0000647_abnormal_sebaceous_gland | 1.03100508 |
| 99 | MP0003634_abnormal_glial_cell | 1.02216707 |
| 100 | MP0005395_other_phenotype | 1.02175127 |
| 101 | MP0005647_abnormal_sex_gland | 1.01941946 |
| 102 | MP0001502_abnormal_circadian_rhythm | 1.01881457 |
| 103 | MP0000538_abnormal_urinary_bladder | 1.01229596 |
| 104 | MP0001545_abnormal_hematopoietic_system | 1.00642903 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 1.00642903 |
| 106 | MP0002938_white_spotting | 0.99590973 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.99559967 |
| 108 | MP0002733_abnormal_thermal_nociception | 0.99315089 |
| 109 | MP0001764_abnormal_homeostasis | 0.99143023 |
| 110 | MP0002229_neurodegeneration | 0.98858478 |
| 111 | MP0003878_abnormal_ear_physiology | 0.98212681 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.98212681 |
| 113 | MP0000653_abnormal_sex_gland | 0.97614169 |
| 114 | MP0002210_abnormal_sex_determination | 0.95618905 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.95335455 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.95238627 |
| 117 | MP0001919_abnormal_reproductive_system | 0.94997932 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.93967618 |
| 119 | * MP0002882_abnormal_neuron_morphology | 0.93949141 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.92842063 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.92815243 |
| 122 | MP0005391_vision/eye_phenotype | 0.92576451 |
| 123 | MP0002254_reproductive_system_inflammat | 0.91961223 |
| 124 | MP0001145_abnormal_male_reproductive | 0.91707412 |
| 125 | MP0000955_abnormal_spinal_cord | 0.88917451 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.86231478 |
| 127 | * MP0002066_abnormal_motor_capabilities/c | 0.85225867 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.85065197 |
| 129 | MP0005310_abnormal_salivary_gland | 0.84223755 |
| 130 | MP0009278_abnormal_bone_marrow | 0.84015571 |
| 131 | MP0005387_immune_system_phenotype | 0.82948829 |
| 132 | MP0001790_abnormal_immune_system | 0.82948829 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.82036912 |
| 134 | MP0006072_abnormal_retinal_apoptosis | 0.81733588 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 0.80372120 |
| 136 | MP0000383_abnormal_hair_follicle | 0.80063942 |
| 137 | MP0009764_decreased_sensitivity_to | 0.79298132 |
| 138 | MP0001119_abnormal_female_reproductive | 0.78479757 |
| 139 | MP0010329_abnormal_lipoprotein_level | 0.77661430 |
| 140 | MP0002168_other_aberrant_phenotype | 0.77539368 |
| 141 | MP0010386_abnormal_urinary_bladder | 0.77532428 |
| 142 | MP0003122_maternal_imprinting | 0.76991970 |
| 143 | MP0001984_abnormal_olfaction | 0.76974513 |
| 144 | MP0003283_abnormal_digestive_organ | 0.75984783 |
| 145 | MP0002233_abnormal_nose_morphology | 0.75056321 |
| 146 | MP0001664_abnormal_digestion | 0.74709247 |
| 147 | MP0003724_increased_susceptibility_to | 0.74098046 |
| 148 | MP0005195_abnormal_posterior_eye | 0.72866958 |
| 149 | MP0002751_abnormal_autonomic_nervous | 0.68478043 |
| 150 | MP0000579_abnormal_nail_morphology | 0.65366616 |
| 151 | MP0003385_abnormal_body_wall | 0.64757173 |
| 152 | MP0005386_behavior/neurological_phenoty | 0.64476992 |
| 153 | MP0004924_abnormal_behavior | 0.64476992 |
| 154 | MP0003937_abnormal_limbs/digits/tail_de | 0.64189942 |
| 155 | MP0005410_abnormal_fertilization | 0.62813868 |
| 156 | MP0004484_altered_response_of | 0.62533552 |
| 157 | MP0003633_abnormal_nervous_system | 0.62374080 |
| 158 | MP0003631_nervous_system_phenotype | 0.62270752 |
| 159 | MP0001851_eye_inflammation | 0.60779555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Septo-optic dysplasia (HP:0100842) | 4.30315237 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.02568067 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.02568067 |
| 4 | Pancreatic fibrosis (HP:0100732) | 3.97151117 |
| 5 | Pancreatic cysts (HP:0001737) | 3.96771297 |
| 6 | Focal motor seizures (HP:0011153) | 3.96515187 |
| 7 | Peripheral hypomyelination (HP:0007182) | 3.76511335 |
| 8 | Absent septum pellucidum (HP:0001331) | 3.67447395 |
| 9 | Upper limb muscle weakness (HP:0003484) | 3.61294313 |
| 10 | True hermaphroditism (HP:0010459) | 3.60603762 |
| 11 | Type II lissencephaly (HP:0007260) | 3.55853360 |
| 12 | White forelock (HP:0002211) | 3.52486161 |
| 13 | Patchy hypopigmentation of hair (HP:0011365) | 3.49580200 |
| 14 | Pendular nystagmus (HP:0012043) | 3.48008844 |
| 15 | * Attenuation of retinal blood vessels (HP:0007843) | 3.44578860 |
| 16 | Abnormality of the renal cortex (HP:0011035) | 3.43442884 |
| 17 | * Abnormal rod and cone electroretinograms (HP:0008323) | 3.40089556 |
| 18 | Ulnar claw (HP:0001178) | 3.31168520 |
| 19 | * Decreased central vision (HP:0007663) | 3.29089662 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.23764680 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.23764680 |
| 22 | Abnormality of the septum pellucidum (HP:0007375) | 3.21453918 |
| 23 | Decreased circulating renin level (HP:0003351) | 3.19574753 |
| 24 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.18263005 |
| 25 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.14170459 |
| 26 | Hypoplasia of the fovea (HP:0007750) | 3.14170459 |
| 27 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.13786122 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 3.02549285 |
| 29 | Febrile seizures (HP:0002373) | 3.00873243 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.99261300 |
| 31 | Nephronophthisis (HP:0000090) | 2.96440016 |
| 32 | Methylmalonic aciduria (HP:0012120) | 2.90095087 |
| 33 | Cerebellar dysplasia (HP:0007033) | 2.87434671 |
| 34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.87155065 |
| 35 | Hemiparesis (HP:0001269) | 2.85238730 |
| 36 | Intestinal atresia (HP:0011100) | 2.83819575 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.82369200 |
| 38 | * Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.82154728 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.81433137 |
| 40 | Prostate neoplasm (HP:0100787) | 2.79186470 |
| 41 | Optic nerve hypoplasia (HP:0000609) | 2.76031514 |
| 42 | Renal cortical cysts (HP:0000803) | 2.75294900 |
| 43 | Onion bulb formation (HP:0003383) | 2.68892362 |
| 44 | Abnormality of the renal medulla (HP:0100957) | 2.67927282 |
| 45 | Cystic liver disease (HP:0006706) | 2.65905702 |
| 46 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.65435422 |
| 47 | Absent/shortened dynein arms (HP:0200106) | 2.65435422 |
| 48 | Hyperglycinuria (HP:0003108) | 2.63156299 |
| 49 | Abnormality of macular pigmentation (HP:0008002) | 2.63096573 |
| 50 | Parakeratosis (HP:0001036) | 2.62562903 |
| 51 | Neoplasm of the adrenal cortex (HP:0100641) | 2.61779642 |
| 52 | Tubular atrophy (HP:0000092) | 2.61333958 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.59155402 |
| 54 | Alacrima (HP:0000522) | 2.55224212 |
| 55 | Abnormal ciliary motility (HP:0012262) | 2.54559003 |
| 56 | Hypokalemic alkalosis (HP:0001949) | 2.51069448 |
| 57 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.49720230 |
| 58 | Anomalous pulmonary venous return (HP:0010772) | 2.49195697 |
| 59 | Decreased lacrimation (HP:0000633) | 2.46902545 |
| 60 | Short tibia (HP:0005736) | 2.46685865 |
| 61 | Abnormal drinking behavior (HP:0030082) | 2.43642637 |
| 62 | Polydipsia (HP:0001959) | 2.43642637 |
| 63 | Osteomalacia (HP:0002749) | 2.42257655 |
| 64 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.41585204 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.41394850 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.41224692 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.40239716 |
| 68 | Abnormality of the fovea (HP:0000493) | 2.38829441 |
| 69 | Aplasia cutis congenita (HP:0001057) | 2.37711775 |
| 70 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.30829904 |
| 71 | Abnormal auditory evoked potentials (HP:0006958) | 2.30350240 |
| 72 | Abnormal biliary tract physiology (HP:0012439) | 2.28442248 |
| 73 | Bile duct proliferation (HP:0001408) | 2.28442248 |
| 74 | Stomach cancer (HP:0012126) | 2.25221296 |
| 75 | Sensory axonal neuropathy (HP:0003390) | 2.24308238 |
| 76 | Duplicated collecting system (HP:0000081) | 2.24077346 |
| 77 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.23421644 |
| 78 | Anencephaly (HP:0002323) | 2.21033966 |
| 79 | * Bony spicule pigmentary retinopathy (HP:0007737) | 2.19959360 |
| 80 | Chorioretinal atrophy (HP:0000533) | 2.19283384 |
| 81 | Morphological abnormality of the inner ear (HP:0011390) | 2.18507059 |
| 82 | Abnormality of the pulmonary veins (HP:0011718) | 2.18165573 |
| 83 | Colon cancer (HP:0003003) | 2.17483060 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13688998 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.13688998 |
| 86 | Abnormality of the renal collecting system (HP:0004742) | 2.13238159 |
| 87 | Abnormality of incisor morphology (HP:0011063) | 2.12818354 |
| 88 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.12595965 |
| 89 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.10016905 |
| 90 | Xerostomia (HP:0000217) | 2.09755774 |
| 91 | Focal seizures (HP:0007359) | 2.08021623 |
| 92 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.06587054 |
| 93 | Polyuria (HP:0000103) | 2.06504225 |
| 94 | Congenital stationary night blindness (HP:0007642) | 2.06288398 |
| 95 | Conical tooth (HP:0000698) | 2.05376476 |
| 96 | Sclerocornea (HP:0000647) | 2.05118735 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.04466901 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.03200853 |
| 99 | Progressive inability to walk (HP:0002505) | 2.00487533 |
| 100 | Microvesicular hepatic steatosis (HP:0001414) | 1.99742427 |
| 101 | Abnormality of the labia minora (HP:0012880) | 1.99559073 |
| 102 | Hyperaldosteronism (HP:0000859) | 1.98731896 |
| 103 | Recurrent pneumonia (HP:0006532) | 1.98545991 |
| 104 | Ketosis (HP:0001946) | 1.97360268 |
| 105 | Constricted visual fields (HP:0001133) | 1.97243064 |
| 106 | Chromsome breakage (HP:0040012) | 1.96680328 |
| 107 | Renal salt wasting (HP:0000127) | 1.95858906 |
| 108 | Retinal dysplasia (HP:0007973) | 1.95449368 |
| 109 | Lissencephaly (HP:0001339) | 1.94611504 |
| 110 | Inability to walk (HP:0002540) | 1.92536873 |
| 111 | Concave nail (HP:0001598) | 1.91364548 |
| 112 | Hypomagnesemia (HP:0002917) | 1.90653863 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.89816866 |
| 114 | Submucous cleft hard palate (HP:0000176) | 1.89803822 |
| 115 | Cupped ear (HP:0000378) | 1.89371474 |
| 116 | Epileptic encephalopathy (HP:0200134) | 1.89190059 |
| 117 | Craniofacial hyperostosis (HP:0004493) | 1.88471112 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 1.88114383 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88114383 |
| 120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.87795141 |
| 121 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.87795141 |
| 122 | Blue irides (HP:0000635) | 1.87200988 |
| 123 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86833947 |
| 124 | Duplication of thumb phalanx (HP:0009942) | 1.85925618 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 1.85638192 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85046984 |
| 127 | Obstructive lung disease (HP:0006536) | 1.85046984 |
| 128 | Metabolic alkalosis (HP:0200114) | 1.84150421 |
| 129 | Abnormality of the axillary hair (HP:0100134) | 1.83989167 |
| 130 | Abnormality of secondary sexual hair (HP:0009888) | 1.83989167 |
| 131 | Corneal dystrophy (HP:0001131) | 1.83979479 |
| 132 | Absent speech (HP:0001344) | 1.83950650 |
| 133 | Keratoconus (HP:0000563) | 1.83938854 |
| 134 | Increased corneal curvature (HP:0100692) | 1.83938854 |
| 135 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83676490 |
| 136 | Hypoplasia of the iris (HP:0007676) | 1.83631846 |
| 137 | Methylmalonic acidemia (HP:0002912) | 1.83611904 |
| 138 | Chin dimple (HP:0010751) | 1.83608332 |
| 139 | Ependymoma (HP:0002888) | 1.83586805 |
| 140 | Nasolacrimal duct obstruction (HP:0000579) | 1.83150716 |
| 141 | Ketoacidosis (HP:0001993) | 1.83028165 |
| 142 | Broad-based gait (HP:0002136) | 1.81167318 |
| 143 | Myelomeningocele (HP:0002475) | 1.79766842 |
| 144 | Furrowed tongue (HP:0000221) | 1.79091127 |
| 145 | Decreased motor nerve conduction velocity (HP:0003431) | 1.78997276 |
| 146 | Severe muscular hypotonia (HP:0006829) | 1.78758297 |
| 147 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.78666301 |
| 148 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78666301 |
| 149 | Aplasia involving bones of the extremities (HP:0009825) | 1.78666301 |
| 150 | Hypothermia (HP:0002045) | 1.78272264 |
| 151 | Median cleft lip (HP:0000161) | 1.78083146 |
| 152 | Severe visual impairment (HP:0001141) | 1.77502754 |
| 153 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77179557 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.76968862 |
| 155 | Abnormality of the parietal bone (HP:0002696) | 1.76104816 |
| 156 | Chronic diarrhea (HP:0002028) | 1.76100827 |
| 157 | Paraparesis (HP:0002385) | 1.75694819 |
| 158 | Congenital primary aphakia (HP:0007707) | 1.74895221 |
| 159 | Tubulointerstitial abnormality (HP:0001969) | 1.74831170 |
| 160 | Abnormality of renin-angiotensin system (HP:0000847) | 1.74035030 |
| 161 | Supranuclear gaze palsy (HP:0000605) | 1.73556592 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.73412421 |
| 163 | Hyperalaninemia (HP:0003348) | 1.73412421 |
| 164 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73412421 |
| 165 | Inflammation of the large intestine (HP:0002037) | 1.72438968 |
| 166 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.72411061 |
| 167 | Hypoplastic pelvis (HP:0008839) | 1.71249915 |
| 168 | Gait imbalance (HP:0002141) | 1.70650013 |
| 169 | Partial agenesis of the corpus callosum (HP:0001338) | 1.70531903 |
| 170 | Drooling (HP:0002307) | 1.69883839 |
| 171 | Genital tract atresia (HP:0001827) | 1.69733233 |
| 172 | Hyperventilation (HP:0002883) | 1.69589849 |
| 173 | Large for gestational age (HP:0001520) | 1.69507919 |
| 174 | Hyperglycinemia (HP:0002154) | 1.69113751 |
| 175 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.68063243 |
| 176 | Steppage gait (HP:0003376) | 1.67394604 |
| 177 | Humeroradial synostosis (HP:0003041) | 1.67109718 |
| 178 | Synostosis involving the elbow (HP:0003938) | 1.67109718 |
| 179 | Bradycardia (HP:0001662) | 1.66451679 |
| 180 | Abnormality of the lacrimal duct (HP:0011481) | 1.66430916 |
| 181 | Aplasia of the musculature (HP:0100854) | 1.65597090 |
| 182 | Mixed hearing impairment (HP:0000410) | 1.65547323 |
| 183 | Metaphyseal dysplasia (HP:0100255) | 1.64361213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.38492629 |
| 2 | CASK | 5.07907622 |
| 3 | MUSK | 4.02024162 |
| 4 | MAP4K2 | 3.52191627 |
| 5 | NUAK1 | 2.95022864 |
| 6 | TNIK | 2.71919854 |
| 7 | BLK | 2.68311570 |
| 8 | PKN1 | 2.52756427 |
| 9 | STK39 | 2.29487155 |
| 10 | MAP3K4 | 2.22593010 |
| 11 | INSRR | 2.21887207 |
| 12 | VRK2 | 2.02950825 |
| 13 | GRK1 | 1.92691775 |
| 14 | PINK1 | 1.91785148 |
| 15 | NTRK3 | 1.82966189 |
| 16 | OXSR1 | 1.80552809 |
| 17 | BMPR1B | 1.74670877 |
| 18 | WNK3 | 1.66688519 |
| 19 | MST4 | 1.65312537 |
| 20 | FGFR2 | 1.62355358 |
| 21 | ADRBK2 | 1.60397386 |
| 22 | MAP3K13 | 1.59157155 |
| 23 | PRPF4B | 1.51349217 |
| 24 | MAPK13 | 1.51076215 |
| 25 | YES1 | 1.48156864 |
| 26 | DAPK2 | 1.47396752 |
| 27 | CLK1 | 1.43398302 |
| 28 | ACVR1B | 1.39820581 |
| 29 | NEK6 | 1.39795440 |
| 30 | MKNK2 | 1.38525560 |
| 31 | TAOK3 | 1.35790747 |
| 32 | PBK | 1.35596704 |
| 33 | BMPR2 | 1.33200512 |
| 34 | PTK2B | 1.29989861 |
| 35 | STK16 | 1.27592799 |
| 36 | SIK3 | 1.25554631 |
| 37 | GRK7 | 1.25294009 |
| 38 | MAP3K14 | 1.21311917 |
| 39 | TLK1 | 1.18697775 |
| 40 | PLK4 | 1.14384021 |
| 41 | EIF2AK2 | 1.12200758 |
| 42 | VRK1 | 1.11950616 |
| 43 | STK3 | 1.11530073 |
| 44 | MAP4K1 | 1.11028427 |
| 45 | MAPKAPK5 | 1.08057498 |
| 46 | BCR | 1.06811152 |
| 47 | MAP2K7 | 1.06801523 |
| 48 | CSNK1A1L | 1.06163629 |
| 49 | RIPK4 | 1.05170247 |
| 50 | FGR | 1.05047267 |
| 51 | MKNK1 | 1.03442716 |
| 52 | CAMK2B | 1.02484588 |
| 53 | EPHA4 | 1.02279938 |
| 54 | MAPK15 | 1.00277943 |
| 55 | FES | 0.99284977 |
| 56 | CAMK2A | 0.98505181 |
| 57 | PRKD2 | 0.95214393 |
| 58 | CDK3 | 0.94563257 |
| 59 | SGK223 | 0.94557042 |
| 60 | SGK494 | 0.94557042 |
| 61 | EPHA3 | 0.94461106 |
| 62 | PRKCE | 0.94422747 |
| 63 | CAMK2D | 0.92865645 |
| 64 | MARK1 | 0.92691416 |
| 65 | DYRK2 | 0.92102471 |
| 66 | NTRK2 | 0.89743017 |
| 67 | CCNB1 | 0.87989081 |
| 68 | CDK8 | 0.86185289 |
| 69 | TNK2 | 0.85964596 |
| 70 | ROCK2 | 0.83957419 |
| 71 | CSNK1G3 | 0.83469472 |
| 72 | FER | 0.83327994 |
| 73 | UHMK1 | 0.82955193 |
| 74 | MELK | 0.82204744 |
| 75 | IRAK4 | 0.81728923 |
| 76 | BRD4 | 0.81084412 |
| 77 | NEK2 | 0.80330536 |
| 78 | STK38L | 0.79985432 |
| 79 | MARK2 | 0.78918800 |
| 80 | PAK3 | 0.78531116 |
| 81 | PLK3 | 0.77643125 |
| 82 | STK11 | 0.77596509 |
| 83 | SIK2 | 0.76462580 |
| 84 | EPHB1 | 0.76229720 |
| 85 | IRAK3 | 0.76057612 |
| 86 | TAF1 | 0.75870102 |
| 87 | WNK4 | 0.75463114 |
| 88 | EIF2AK3 | 0.75451619 |
| 89 | CSNK1G1 | 0.74663155 |
| 90 | PRKCQ | 0.73998163 |
| 91 | WNK1 | 0.73523449 |
| 92 | MAPK12 | 0.73039422 |
| 93 | IRAK1 | 0.72375308 |
| 94 | CAMK1G | 0.72107828 |
| 95 | PNCK | 0.70301584 |
| 96 | AKT3 | 0.70197945 |
| 97 | PIK3CG | 0.69844404 |
| 98 | PHKG1 | 0.69592557 |
| 99 | PHKG2 | 0.69592557 |
| 100 | TXK | 0.69239321 |
| 101 | EIF2AK1 | 0.67994508 |
| 102 | PIK3CA | 0.67047141 |
| 103 | SRPK1 | 0.66904155 |
| 104 | KIT | 0.66707236 |
| 105 | FLT3 | 0.64902051 |
| 106 | DYRK1A | 0.64699123 |
| 107 | PRKG2 | 0.62087031 |
| 108 | TRPM7 | 0.61731600 |
| 109 | MARK3 | 0.60855723 |
| 110 | MAPK7 | 0.60711874 |
| 111 | RPS6KA5 | 0.60285784 |
| 112 | CAMK2G | 0.59930386 |
| 113 | CSNK1G2 | 0.58710385 |
| 114 | CDK19 | 0.58100685 |
| 115 | TIE1 | 0.57423399 |
| 116 | CAMK1 | 0.57213486 |
| 117 | GRK5 | 0.56266843 |
| 118 | PRKAA1 | 0.56117165 |
| 119 | PRKG1 | 0.55619740 |
| 120 | FYN | 0.54833628 |
| 121 | ZAK | 0.54750608 |
| 122 | PRKACA | 0.52441129 |
| 123 | LYN | 0.52366664 |
| 124 | TRIM28 | 0.51444252 |
| 125 | CDK5 | 0.50878800 |
| 126 | CSNK1D | 0.47750679 |
| 127 | IKBKB | 0.46558732 |
| 128 | BRSK2 | 0.46313949 |
| 129 | PRKCI | 0.44864643 |
| 130 | JAK3 | 0.44830759 |
| 131 | CAMKK2 | 0.44827664 |
| 132 | NLK | 0.44689964 |
| 133 | PRKCG | 0.44377351 |
| 134 | RPS6KB1 | 0.44310715 |
| 135 | SGK1 | 0.43731016 |
| 136 | NME1 | 0.42826077 |
| 137 | PRKD1 | 0.42734586 |
| 138 | PRKAA2 | 0.41518518 |
| 139 | IRAK2 | 0.40438977 |
| 140 | CSNK1A1 | 0.39974579 |
| 141 | CSK | 0.39148590 |
| 142 | ADRBK1 | 0.37473010 |
| 143 | PLK2 | 0.37111410 |
| 144 | CAMK1D | 0.36873696 |
| 145 | PLK1 | 0.35695154 |
| 146 | LATS1 | 0.33093147 |
| 147 | PRKCA | 0.31892098 |
| 148 | MAP3K12 | 0.31626512 |
| 149 | PRKCZ | 0.31333280 |
| 150 | PDK2 | 0.29920287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.67504841 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.70517482 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67999207 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.56058625 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43617551 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.29549998 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.28452725 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21649174 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.07104032 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.05840844 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.02423086 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01934137 |
| 13 | Axon guidance_Homo sapiens_hsa04360 | 2.00577137 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.97904938 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.91122627 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90951682 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.89866338 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.89516919 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89076992 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.84052794 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.83794093 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82233828 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81873624 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81252324 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.78908108 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77062090 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.73709038 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.70161599 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.54858761 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.52997615 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50844756 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.50250727 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41373170 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.39332662 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37553593 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34239887 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32444799 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31129066 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.30289552 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30274541 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29458486 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29373684 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28662422 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28340821 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24746342 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.18209584 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16442613 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15075298 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10126449 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09608911 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09276706 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 1.04712631 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04044747 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03473527 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02600209 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.02449327 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00608930 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99394216 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98842904 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94290728 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.92564263 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91847244 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91033295 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87815421 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86673394 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.85976500 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85433578 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84388402 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83407689 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80336615 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80131366 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.80028213 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78796890 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78288175 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75845343 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75260995 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.75260695 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75162590 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75093432 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74824817 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73540584 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.73471990 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.73194985 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72821521 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71157914 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.71148582 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70890819 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70452182 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68984002 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67307406 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.66691429 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66396652 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65835911 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63824249 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63619366 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63379607 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63265478 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62916480 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62528334 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61094678 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60783128 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60608187 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59945386 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59718474 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59213240 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59104722 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57786857 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57660762 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.57255708 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.55238784 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55047953 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54911581 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54073507 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53930157 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.53816658 |
| 116 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53236777 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52720416 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52029393 |
| 119 | Protein export_Homo sapiens_hsa03060 | 0.51378027 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51118599 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.50833392 |
| 122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50288409 |
| 123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49537645 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49495640 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49436543 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49055992 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49016567 |
| 128 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47087135 |
| 129 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46666910 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.45947824 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45912922 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44164653 |
| 133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43889600 |
| 134 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42516656 |
| 135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42268341 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41780688 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | 0.40944153 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39244329 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38717103 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38130572 |
| 141 | Proteasome_Homo sapiens_hsa03050 | 0.35859997 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35207986 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34418137 |

